Cellectis S.A. (ALCLS.PA) Stock Price
€2.51 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
2 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Cellectis S.A., AI stock picks, stock alerts and much more.
ALCLS.PA AI Stock Analysis
AI stock analysis for ALCLS.PA is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Cellectis S.A. (ALCLS.PA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Cellectis S.A. (ALCLS.PA) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Cellectis S.A. (ALCLS.PA), currently trading at €2.51, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About ALCLS.PA
-
Cellectis S.
-
Symbol
ALCLS.PA
-
Market
EURONEXT
-
Industry
Biotechnology
-
Market Cap
181M
Similar Stocks
 |
Valneva SE VLA.PA |
€5.05 2.4% |
5 |
 |
Financière de Tubize SA TUB.BR |
€160.6 0.4% |
8 |
 |
OSE Immunotherapeutics SA OSE.PA |
€6.32 0.5% |
6 |
 |
UCB SA UCB.BR |
€197.3 0.9% |
6 |
 |
Innate Pharma S.A. IPH.PA |
€2.01 1.9% |
5 |
News
ALCLS.PA Alternative Data
Web Traffic
Cellectis S.A. receives an estimated 7143 monthly visitors to cellectis.com.
-
Web Traffic
7143
-
Change from Previous Month
48.2%
-
3 Month Change
1.3%
-
YoY Change
1.3%
Twitter Followers
Cellectis S.A. has 4,392 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.5% over the last month.
-
Twitter Followers
4392
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
0.3%
Youtube Subscribers
Cellectis S.A. has 543 subscribers on its main Youtube channel, up by 0.6% over the last month.
-
Youtube Subscribers
543
-
Daily Change
0%
-
1 Month Change
0.6%
-
3 Month Change
0.4%
Job Postings
Cellectis S.A. currenly has an estimated 19 open job postings, up by 35.7% over the last month.
-
Job Postings
19
-
Daily Change
0%
-
1 Month Change
35.7%
-
3 Month Change
5%
Reddit Mentions
Cellectis S.A. has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
TikTok Followers
Cellectis S.A. has 6 Followers on its main TikTok account.
-
TikTok Followers
6
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, Cellectis S.A. has 236 employees, down by -0.4% over the last month.
-
LinkedIn Employees
236
-
Daily Change
0.4%
-
1 Month Change
0.4%
-
3 Month Change
0.9%
Business Outlook
According to employee reviews, the business outlook among employees at Cellectis S.A. is 28 out of 100 (bearish).
-
Business Outlook
28
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
Cellectis S.A. was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
ALCLS.PA Financials
ALCLS.PA Key Metrics
-
Total Revenue
$12.7M
-
Net Income
$5.9M
-
Earnings per Share
$0.0659
-
Free cash flow
-$1.8M
-
EBITDA
$14.2M
-
EBITDA Ratio
1.11457
-
Total Assets
$383.5M
ALCLS.PA 2-year Revenue & Income
ALCLS.PA 2-year Free Cash Flow
ALCLS.PA Technicals
ALCLS.PA SMA
ALCLS.PA RSI
FAQ
What's the current price of Cellectis S.A. (ALCLS.PA) Stock?
The price of an Cellectis S.A. (ALCLS.PA) share is €2.51.
What's the market cap of Cellectis S.A.?
The current market cap of Cellectis S.A. is 181M.
Should I buy or sell ALCLS.PA?
Cellectis S.A. shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Cellectis S.A. is better viewed as a hold or accumulate position while waiting for further developments.
Is Cellectis S.A. a good investment?
The current analysis of Cellectis S.A.'s fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Cellectis S.A.'s portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Cellectis S.A. (ALCLS.PA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Cellectis S.A. stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Cellectis S.A. (ALCLS.PA) that investors often compare it to?
Cellectis S.A. (ALCLS.PA) is often compared to similar stocks such as Valneva SE, Financière de Tubize SA, OSE Immunotherapeutics SA, UCB SA and Innate Pharma S.A..
What is the forecast for Cellectis S.A.'s stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Cellectis S.A.'s stock price to be around €2.45 in 2026. Starting from the current price of €2.51, this represents a 2.3% change in price, indicating a neutral outlook for the stock.
How to buy Cellectis S.A. (ALCLS.PA) Stock?
Cellectis S.A. stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Cellectis S.A. shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.